SEC Nets $18M From Drug Co. Accused Of Duping Investors
A Massachusetts-based life sciences company was ordered Wednesday to pay $17.9 million to the U.S. Securities and Exchange Commission in a lawsuit accusing the company of selling investors millions of dollars'...To view the full article, register now.
Already a subscriber? Click here to view full article